Chiron Therapeutics
Stem cell research

About Chiron Therapeutics

Pioneering the future of regenerative medicine through innovative stem cell technology

OUR MISSION

We Are On A Bold Mission

To deliver safe, scalable, and effective adult stem cell therapies for patients.

Safety First

Current stem cell methods risk patient safety, creating an urgent need for safer, non-transgenic and virus-free approach to produce scalable adult stem cells for therapy.

High-Yield Production

Our IP-licensed method generates large quantities of tissue-specific adult stem cells from somatic cells without transgenes or viruses.

Enhanced Safety

By eliminating genetic manipulation, our approach significantly reduces the risk of tumorigenesis and genetic instabilities.

Minimally Invasive

Our technology allows for the generation of therapeutic cells from easily accessible tissues like skin, reducing patient discomfort.

Our SIST Technology Process

The Suspension-Induced Stem Cell Transition (SIST) technology is our proprietary method for generating tissue-specific adult stem cells without genetic modification or viral vectors.

SIST Reprogramming Process

Our closed-loop process takes cells from collection to treatment with our revolutionary SIST reprogramming method.

OUR STORY

Our History & Vision

At Chiron Therapeutics, we are reimagining what is possible in cell therapy. Inspired by the legendary healer Chiron, we harness the body's own regenerative power to tackle some of today's most urgent medical challenges.

Our mission is bold and focused: to deliver safe, scalable, and life-changing adult stem cell therapies. Backed by decades of expertise in stem cell biology and clinical translation, our founding team built Chiron around a breakthrough platform—the Suspension-Induced Stem Cell Transition (SIST) method. This patented technology enables unprecedented expansion of adult stem cells, unlocking their full clinical potential.

Unlike the complexity and risk of iPSC-based approaches, our adult stem cell platform offers a faster, safer, and more direct path to the clinic.

From orthopedic injuries to chronic diseases, we are committed to turning advanced science into real-world healing—bridging the gap between innovation and impact.

OUR THERAPEUTICS

Revolutionary Stem Cell Therapies

Chiron Therapeutics is pioneering a new era in regenerative medicine with our innovative SIST platform technology. Our therapeutic approach leverages the power of adult stem cells to create safe, effective, and scalable treatments that address critical unmet medical needs.

Chiron Therapeutics Clinical Pipeline

Our Clinical Development Programs

We're advancing two promising therapeutic pipelines with compelling proof-of-concept data and clear paths to clinical translation:

Orthopedic Disorders

Targeted cartilage regeneration for joint repair and mobility restoration

Skin & Wound Healing

Accelerated healing for burn injuries and chronic wounds

With a focus on real-world applicability and clinical readiness, Chiron is building a pipeline designed to move swiftly from lab to patient.

OUR PEOPLE

Meet the Team Behind Chiron Therapeutics

Our talented team combines world-class scientific expertise with business acumen to transform innovative research into breakthrough therapies.

Behzad Yeganeh, Ph.D.

Behzad Yeganeh, Ph.D.

Chief Executive Officer & Founder

Dr. Yeganeh, with a Ph.D. in Cancer Biology and 15+ years in stem cell research, pioneered the Suspe...

Amit Shrestha, Ph.D.

Amit Shrestha, Ph.D.

Chief Operations Officer

Dr. Shrestha brings a decade of expertise in cell and gene therapy with a Ph.D. in Cellular and Mole...

Dr. James L. Sherley, M.D., Ph.D.

Dr. James L. Sherley, M.D., Ph.D.

Scientific Advisor

Harvard and Johns Hopkins-trained Dr. Sherley is founder and CEO of Asymmetrex®, which pioneered dif...